What accreditation should buyers require when selecting a Biobanking Market service partner?

Require CAP Biorepository Accreditation or ISO 20387 certification at minimum. Both verify documented chain of custody, validated equipment qualification, and competency records. Sponsors running regulated trials should also confirm the site has hosted a successful regulatory inspection [22]. Read More

Should a mid-sized pharmaceutical sponsor insource or outsource repository operations?

Outsource below roughly 500,000 stored vials; the capital and staffing burden rarely clears the hurdle rate at that scale. Insource above it, or where sample sensitivity makes third-party custody a commercial risk [13]. Read More

How does LIMS integration typically fail in Biobanking Market deployments?

Failures cluster around metadata schema mismatch between clinical source systems and repository software. Budget six to nine months for mapping and validation. Insist on API-level interoperability rather than flat-file exchange during vendor selection [9]. Read More

When is vapour-phase nitrogen storage necessary instead of −80 °C freezers?

Viable cell products, stem cells, and anything intended for clinical administration require vapour-phase nitrogen below −150 °C. Nucleic acids, serum, and most tissue for molecular analysis remain stable at −80 °C [15]. Read More

What consent model best supports secondary research use in the Biobanking Market?

Broad consent with a dynamic re-contact mechanism performs best. It preserves future research flexibility while giving participants granular withdrawal rights, satisfying both GDPR special-category requirements and most institutional review boards [8]. Read More

How should operators hedge liquid nitrogen supply risk?

Contract dual suppliers with separate production sources and maintain on-site reserve capacity covering seven to ten days. Nitrogen generators become economic above sustained daily consumption thresholds, though they add maintenance overhead [17]. Read More

What emerging use cases will reshape demand after 2030?

Microbiome and single-cell reference collections are the likeliest growth vectors, both requiring preservation chemistry that current workflows handle poorly. Environmental and agricultural repositories represent a second adjacency drawing on the same cold-chain infrastructure [6]. Read More

Biobanking Market (2025 - 2035)

Biobanking Market Research Report: Size, Share, Trend Analysis By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Applications (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End-use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations), By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025-2035

CAGR

5.27%

2025 Market Size

USD 51.32 Billion

2035 Market Size

USD 85.77 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/4511-HCR | Pages: 200 | Author: Rahul Gotadki, Kinjoll Dey

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Report Takeaways |
1. 2.1 By Equipment |
2. 2.2 By Application and Ownership |
3. 2.3 By Geography
3 Global Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2025) |
2. 3.2 Current & Forecast Market Size (2026–2035) |
3. 3.3 Year-over-Year Growth Analysis
4 Market Drivers Analysis |
1. 4.1 Precision Medicine Rewrites the Specification |
2. 4.2 Donor-Eligibility Guidance Removes a Pricing Overhang |
3. 4.3 Cord Blood and Cell Therapy Pull Hospitals In |
4. 4.4 Automation Economics Clear the Hurdle Rate
5 Market Restraints Analysis |
1. 5.1 Capital Intensity of Automated Infrastructure |
2. 5.2 Consent Fragmentation and Cross-Border Transfer |
3. 5.3 Sample Utilisation and Quality Variability
6 Market Opportunity Analysis |
1. 6.1 Federated Access Platforms as a Revenue Layer |
2. 6.2 Emerging-Market Population Cohorts |
3. 6.3 AI Quality Scoring as a Premium Service |
4. 6.4 Decentralised and Home-Collection Workflows |
5. 6.5 Sustainability-Linked Retrofits |
6. 6.6 Industry Value Chain Analysis |
7. 6.7 Porter's Five Forces Analysis
7 Regional Analysis |
1. 7.1 North America | |
  1. 7.1.1 United States | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 United Kingdom | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Autonomous Repository Operations |
2. 8.2 Platform Economics and Access Fees |
3. 8.3 Energy and the Sustainability Ledger |
4. 8.4 Consolidation and Vertical Integration
9 Segmentation Analysis |
1. 9.1 By Equipment | |
  1. 9.1.1 Cryogenic Storage Systems | | |
    1. 9.1.1.1 Refrigerators | | |
    2. 9.1.1.2 Freezers | | |
    3. 9.1.1.3 Ice Machines | |
  2. 9.1.2 Alarm and Monitoring Systems | |
  3. 9.1.3 Media & Consumables |
2. 9.2 By Application | |
  1. 9.2.1 Regenerative Medicine | |
  2. 9.2.2 Drug Discovery | |
  3. 9.2.3 Clinical Diagnostics | |
  4. 9.2.4 Life Science Research | |
  5. 9.2.5 Other Applications |
3. 9.3 By Ownership Type | |
  1. 9.3.1 Public / Government | |
  2. 9.3.2 Academic / Non-profit | |
  3. 9.3.3 Private / Commercial | |
  4. 9.3.4 Hospital-Based
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Thermo Fisher Scientific | |
  2. 10.3.2 Becton Dickinson | |
  3. 10.3.3 Azenta Life Sciences | |
  4. 10.3.4 Merck KGaA | |
  5. 10.3.5 Danaher (Beckman Coulter) | |
  6. 10.3.6 Hamilton Company | |
  7. 10.3.7 BioLife Solutions | |
  8. 10.3.8 PHC Holdings | |
  9. 10.3.9 QIAGEN | |
  10. 10.3.10 Avantor | |
  11. 10.3.11 Greiner Bio-One | |
  12. 10.3.12 Cryoport Systems
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Valuation Currency & Conversion |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Biobanking Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Biobanking Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis – Estimated Contribution to CAGR, 2026–2035 |
TABLE 4 Restraint Impact Analysis – Estimated Drag on CAGR, 2026–2035 |
TABLE 5 Global Biobanking Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Biobanking Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Biobanking Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Biobanking Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Biobanking Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Biobanking Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Biobanking Market Size, by Equipment, 2021–2035 (USD Billion) |
TABLE 12 Global Biobanking Market Size, by Cryogenic Storage Sub-Type, 2021–2035 (USD Billion) |
TABLE 13 Global Biobanking Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 14 Global Biobanking Market Size, by Ownership Type, 2021–2035 (USD Billion) |
TABLE 15 North America Biobanking Market Size, by Equipment, 2021–2035 (USD Billion) |
TABLE 16 North America Biobanking Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 17 Europe Biobanking Market Size, by Equipment, 2021–2035 (USD Billion) |
TABLE 18 Europe Biobanking Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 19 Asia-Pacific Biobanking Market Size, by Equipment, 2021–2035 (USD Billion) |
TABLE 20 Asia-Pacific Biobanking Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 21 South America Biobanking Market Size, by Ownership Type, 2021–2035 (USD Billion) |
TABLE 22 Middle East & Africa Biobanking Market Size, by Ownership Type, 2021–2035 (USD Billion) |
TABLE 23 Competitive Benchmarking Matrix – Global Biobanking Market, 2026 |
TABLE 24 Company Profiles – Key Players, Global Biobanking Market |
TABLE 25 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 26 Report Scope & Methodology Summary |
TABLE 27 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Global Biobanking Market Dynamics – Drivers, Restraints, Opportunities |
FIGURE 2 Industry Value Chain Analysis – Collection to Data Access |
FIGURE 3 Porter's Five Forces Analysis, 2026 |
FIGURE 4 Global Market Size Trend Line, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Trajectory, 2022–2035 (%) |
FIGURE 6 Market Share by Equipment, 2025 vs 2035 (%) |
FIGURE 7 Market Share by Application, 2025 vs 2035 (%) |
FIGURE 8 Market Share by Ownership Type, 2025 (%) |
FIGURE 9 Regional Revenue Share Distribution, 2025 (%) |
FIGURE 10 Regional CAGR Comparison, 2026–2035 (%) |
FIGURE 11 Country-Level Revenue Concentration – Top 10 Markets, 2025 |
FIGURE 12 Competitive Landscape – Estimated Revenue Share Bands, 2026 |
FIGURE 13 Strategic Positioning Matrix – Automation Depth vs Service Breadth |
FIGURE 14 Cold-Chain Energy Intensity Benchmark by Storage Class

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Equipment	Cryogenic Storage Systems (Refrigerators, Freezers, Ice Machines); Alarm and Monitoring Systems; Media & Consumables	Cryogenic Storage Systems	Freezers
By Application	Regenerative Medicine; Drug Discovery; Clinical Diagnostics; Life Science Research; Other Applications	Regenerative Medicine	Clinical Diagnostics
By Ownership Type	Public/Government; Academic/Non-profit; Private/Commercial; Hospital-Based	Public / Government	Academic / Non-profit
By Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Equipment

Sub-Segment	Key Trend
Cryogenic Storage Systems	Vapour-phase nitrogen vaults replacing mechanical-only architectures for clinical-grade material
Refrigerators	Short-hold units increasingly bundled with automated inventory verification.
Freezers	Set-point elevation to −70 °C gaining acceptance as an energy-cost lever
Ice Machines	Commoditised; demand tracks preanalytical transport volume rather than technology change.
Alarm and Monitoring Systems	Cloud telemetry and predictive excursion alerts becoming an audit prerequisite.
Media & Consumables	Recurring revenue anchor; cryoprotectant chemistry advancing for cell-therapy viability

Equipment demand is bifurcating. High-value cryogenic and monitoring assets attract capital scrutiny and long procurement cycles, while consumables generate the predictable annuity that finances replacement. Vendors capable of selling both under a single service agreement are winning the largest institutional contracts.

By Application

Sub-Segment	Key Trend
Regenerative Medicine	Commercial cell and gene therapy launches pulling storage demand from research into manufacturing.
Drug Discovery	Sponsors retain data rights while outsourcing physical custody of annotated collections.
Clinical Diagnostics	Companion diagnostic development driving demand for matched tumour-normal specimen sets.
Life Science Research	Multi-omics readiness now a baseline specification rather than a premium option
Other Applications	Forensic, veterinary, and agricultural repositories adopting clinical-grade cold-chain standards

Application mix determines pricing power. Clinical and therapeutic uses command materially higher revenue per vial than archival research storage because they carry validation, documentation, and liability obligations that pure research collections do not.

By Ownership Type

Sub-Segment	Key Trend
Public / Government	National cohort mandates and preparedness funding sustain the largest single procurement base.
Academic / Non-profit	Grant conditions requiring specimen retention accelerating capacity additions
Private / Commercial	Outsourced custody models and cord-blood services expanding recurring contract revenue
Hospital-Based	Proximity to patient consent creating strategic leverage over downstream data rights

Ownership structure predicts investment behaviour more reliably than geography. Public and hospital operators optimise for compliance and continuity; commercial operators optimise for utilisation and margin. That divergence shapes which vendors and contract structures each group selects.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”